Literature DB >> 17337248

Mortality in epilepsy.

Nikolas Hitiris1, Rajiv Mohanraj, John Norrie, Martin J Brodie.   

Abstract

All studies report an increased mortality risk for people with epilepsy compared with the general population. Population-based studies have demonstrated that the increased mortality is often related to the cause of the epilepsy. Common etiologies include neoplasia, cerebrovascular disease, and pneumonia. Deaths in selected cohorts, such as sudden unexpected death in epilepsy (SUDEP), status epilepticus (SE), suicides, and accidents are more frequently epilepsy-related. SUDEP is a particular cause for concern in younger people, and whether and when SUDEP should be discussed with patients with epilepsy remain problematic issues. Risk factors for SUDEP include generalized tonic-clonic seizures, increased seizure frequency, concomitant learning disability, and antiepileptic drug polypharmacy. The overall incidence of SE may be increasing, although case fatality rates remain constant. Mortality is frequently secondary to acute symptomatic disorders. Poor compliance with treatment in patients with epilepsy accounts for a small proportion of deaths from SE. The incidence of suicide is increased, particularly for individuals with epilepsy and comorbid psychiatric conditions. Late mortality figures in patients undergoing epilepsy surgery vary and are likely to reflect differences in case selection. Future studies of mortality should be prospective and follow agreed guidelines to better quantify risk and causation in individual populations.

Entities:  

Mesh:

Year:  2007        PMID: 17337248     DOI: 10.1016/j.yebeh.2007.01.005

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  16 in total

Review 1.  The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson
Journal:  Epilepsia       Date:  2016-11-26       Impact factor: 5.864

Review 2.  The interictal dysphoric disorder of epilepsy: a still open debate.

Authors:  Marco Mula
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

3.  Neurology's Silent Killer: Drug-Resistant Epilepsy.

Authors:  Lara Jehi
Journal:  Epilepsy Curr       Date:  2016 Jul-Aug       Impact factor: 7.500

4.  Cost effectiveness of lacosamide in the adjunctive treatment of patients with refractory focal epilepsy in Belgium.

Authors:  Steven Simoens; Liesbet De Naeyer; Peter Dedeken
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

5.  Suicidality in people taking antiepileptic drugs: What is the evidence?

Authors:  Gail S Bell; Marco Mula; Josemir W Sander
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 6.  Seizure-related injuries, drowning and vehicular crashes -- a critical review of the literature.

Authors:  Michael Tan; Wendyl D'Souza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

7.  Antiepileptic drugs and suicidality.

Authors:  Jeffery W Britton; Jerry J Shih
Journal:  Drug Healthc Patient Saf       Date:  2010-09-28

8.  Electrocardiographic Abnormalities and Mortality in Epilepsy Patients.

Authors:  Normunds Suna; Inga Suna; Evija Gutmane; Linda Kande; Guntis Karelis; Ludmila Viksna; Valdis Folkmanis
Journal:  Medicina (Kaunas)       Date:  2021-05-16       Impact factor: 2.430

9.  A review of the epidemiology of temporal lobe epilepsy.

Authors:  Jose F Téllez-Zenteno; Lizbeth Hernández-Ronquillo
Journal:  Epilepsy Res Treat       Date:  2011-12-29

10.  Utilizing multimodal imaging to visualize potential mechanism for sudden death in epilepsy.

Authors:  Ranajay Mandal; Ryan Budde; Georgia L Lawlor; Pedro Irazoqui
Journal:  Epilepsy Behav       Date:  2021-07-05       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.